Trifluoperazine, a dopamine receptor antagonist commonly prescribed for schizophrenia, used in combination with radiation therapy delays the growth of glioblastoma brain tumors and prolongs survival for brain cancer.
Cannabidiol (CBD) appears to slow the growth of glioblastoma brain cancer cells in both animal and human cell lines. CBD's anti-cancer actions target mitochondria, causing them to dysfunction and release harmful reactive oxygen species. Cancer cells treated with CBD exhibited significant decreases in mitochondrial activity.
Combining niacin, or vitamin B3, with chemotherapy, helped slow the progression and increase life span in mouse models of glioblastoma.
Artificial IntelligenceBrain CancerDeep LearningFeaturedMachine LearningNeurologyNeuroscienceNeurotech
··3 min readA new machine learning algorithm can predict which tumors were lower-grade gliomas or glioblastoma brain cancer with a high degree of accuracy.
Several variants of the PIK3CA gene drive brain tumor progression. Two of the variants alter the expression of genes involved in synapses.
A new brain chip allows multiple simultaneous drugs to be administered directly to glioblastoma brain cancer tumors.
Introducing VEGF-C into the cerebrospinal fluid of mouse models of glioblastoma, researchers noted increased levels of T cell response to the cancerous tumors. When combined with immune system checkpoint inhibitors, the VEGF-C treatment significantly extended the life span of the mice with glioblastoma brain cancer.
Extra DNA is critical for maintaining cancer-causing gene activation and supporting the cancer cell's ability to survive.
A new study raises questions about the link between cell phone use and an increased risk of developing brain cancer. Researchers found little evidence to suggest the rate of brain cancer incidents has risen in any age group as a result of cell phone usage.
Surfen, a compound molecule used for drug delivery of insulin could block tumor growth for patients with glioblastoma brain cancer.
Glioblastoma stem cells' circadian clocks ramp up the cells' metabolism, making them stronger, more resistant to treatment, and able to divide and multiply more rapidly. By targeting the stem cells with a small molecule drug, researchers found mice models lived longer and their tumors shrank.
Novel biomarkers for glioblastoma brain cancer have been identified in bodily fluids. The discovery may lead to a new, simple, non-invasive blood test to detect brain cancer in the future.
